Spironolactone - Heart failure

You are here : Home > Formulary Search > Spironolactone - Heart failure

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green

Formulations :

Oral solution
Tablets

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Associated Icons :

Guidelines

SPC

Restrictions / Comments :

Important

Preferred

Spironolactone is the preferred aldosterone antagonist for all stages of heart failure.

Documentation

Guidelines (Local)

Spironolactone monitoring in combination with Renin-angiotensin - Jul 16

PAD Profile

ChemicalSubstance :

Spironolactone

Indication :

Heart failure

Group Name :

Keywords :

potassium sparing diuretics, aldosterone antagonists, hyperkalaemia

Brand Names Include :

Aldactone

Important Information :

Latest Additions Date From :

Latest Additions Date To :

Guidelines :

Heart failure

Supporting Documents :

Committee Recommendations (1)

03 May 17 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

GENERIC Spironolactone has been considered by the PCN and has been assigned a GREEN traffic light status.

NOTE - the branded product, Aldactone, was considered BLACK at the PCN in May 2017.

SAFETY NOTICE: In Feb 2016 the MHRA highlighted the risk of potentially fatal hyperkalaemia when spironolactone is used in combination with a renin-angiotensin drug in heart failure. The MCG approved the content of a guide which clarifies the monitoring requirements for patients on this combination - see guide below

Other Indications

Below are listed other indications that Spironolactone is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Heart failure.